Skip to content

Cardinal Health CAH Investing Cash Flow

Investing Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
-$3.92B-16.8%
Alpha Pro Tech logo
Alpha Pro TechAPT
-$117K+13.3%
McKesson logo
McKessonMCK
-$269M-97.8%
Cencora logo
CencoraCOR
-$4.87B-19.6%
AbbVie logo
AbbVieABBV
-$574M+21.9%
Avanos Medical logo
Avanos MedicalAVNS
-$7.7M+15.4%

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$55.64B+41.6%
Enterprise value$60.62B+34.8%
P/E35.8×+10.6×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%
Debt / equity4.1×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's investing cash flow?
Cardinal Health (CAH) reported investing cash flow of -$181M in Q1 2026.
How has Cardinal Health's investing cash flow changed year-over-year?
Cardinal Health's investing cash flow increased by 93.8% year-over-year, from -$2.9B to -$181M.
What is the long-term trend for Cardinal Health's investing cash flow?
Over 2 years (2023 to 2025), Cardinal Health's investing cash flow has grown at a 251.0% compound annual growth rate (CAGR), from -$454M to -$5.59B.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.